Chrysea – delivering precision, healthy lifespan nutritional intervention based on credible scientific evidence

Published at

Chrysea’s CEO explains more about the company, financial raises, Intellectual Property and its fit in the Longevity Biotech field.

In the first of two interviews with Longevity Technology, Chrysea’s CEO explains more about the company, financial raises, Intellectual Property and its fit in the Longevity Biotech field.

Go to the news index